Literature DB >> 31877385

Loss of ELK1 has differential effects on age-dependent organ fibrosis.

Jennifer T Cairns1, Anthony Habgood1, Rochelle C Edwards-Pritchard1, Chitra Joseph1, Alison E John1, Chloe Wilkinson1, Iain D Stewart1, Jack Leslie2, Burns C Blaxall3, Katalin Susztak4, Siegfried Alberti5, Alfred Nordheim6, Fiona Oakley2, Gisli Jenkins1, Amanda L Tatler7.   

Abstract

ETS domain-containing protein-1 (ELK1) is a transcription factor important in regulating αvβ6 integrin expression. αvβ6 integrins activate the profibrotic cytokine Transforming Growth Factor β1 (TGFβ1) and are increased in the alveolar epithelium in idiopathic pulmonary fibrosis (IPF). IPF is a disease associated with aging and therefore we hypothesised that aged animals lacking Elk1 globally would develop spontaneous fibrosis in organs where αvβ6 mediated TGFβ activation has been implicated. Here we identify that Elk1-knockout (Elk1-/0) mice aged to one year developed spontaneous fibrosis in the absence of injury in both the lung and the liver but not in the heart or kidneys. The lungs of Elk1-/0 aged mice demonstrated increased collagen deposition, in particular collagen 3α1, located in small fibrotic foci and thickened alveolar walls. Despite the liver having relatively low global levels of ELK1 expression, Elk1-/0 animals developed hepatosteatosis and fibrosis. The loss of Elk1 also had differential effects on Itgb1, Itgb5 and Itgb6 expression in the four organs potentially explaining the phenotypic differences in these organs. To understand the potential causes of reduced ELK1 in human disease we exposed human lung epithelial cells and murine lung slices to cigarette smoke extract, which lead to reduced ELK1 expression andmay explain the loss of ELK1 in human disease. These data support a fundamental role for ELK1 in protecting against the development of progressive fibrosis via transcriptional regulation of beta integrin subunit genes, and demonstrate that loss of ELK1 can be caused by cigarette smoke.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Ageing; CSE; ELK1; Fibrosis; Gene regulation; Integrin; Liver; Lung; TGFβ

Mesh:

Substances:

Year:  2019        PMID: 31877385      PMCID: PMC9364830          DOI: 10.1016/j.biocel.2019.105668

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.652


  33 in total

Review 1.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

2.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

3.  TGF-β activation and lung fibrosis.

Authors:  Amanda L Tatler; Gisli Jenkins
Journal:  Proc Am Thorac Soc       Date:  2012-07

4.  Pharmacologic Blockade of αvβ1 Integrin Ameliorates Renal Failure and Fibrosis In Vivo.

Authors:  Yongen Chang; Wei Ling Lau; Hyunil Jo; Kazuyuki Tsujino; Leslie Gewin; Nilgun Isik Reed; Amha Atakilit; Ane Claudia Fernandes Nunes; William F DeGrado; Dean Sheppard
Journal:  J Am Soc Nephrol       Date:  2017-02-20       Impact factor: 10.121

5.  The effects of intrinsic pathway protease deficiencies on plasminogen-deficient mice.

Authors:  Qiufang Cheng; Yong Zhao; William E Lawson; Vasiliy V Polosukhin; Joyce E Johnson; Timothy S Blackwell; David Gailani
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

6.  Role of alphavbeta6 integrin in acute biliary fibrosis.

Authors:  Bruce Wang; Brian M Dolinski; Noriko Kikuchi; Diane R Leone; Marion G Peters; Paul H Weinreb; Shelia M Violette; D Montgomery Bissell
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

7.  Telomerase mutations in families with idiopathic pulmonary fibrosis.

Authors:  Mary Y Armanios; Julian J-L Chen; Joy D Cogan; Jonathan K Alder; Roxann G Ingersoll; Cheryl Markin; William E Lawson; Mingyi Xie; Irma Vulto; John A Phillips; Peter M Lansdorp; Carol W Greider; James E Loyd
Journal:  N Engl J Med       Date:  2007-03-29       Impact factor: 91.245

8.  Telomere shortening in familial and sporadic pulmonary fibrosis.

Authors:  Jennifer T Cronkhite; Chao Xing; Ganesh Raghu; Kelly M Chin; Fernando Torres; Randall L Rosenblatt; Christine Kim Garcia
Journal:  Am J Respir Crit Care Med       Date:  2008-07-17       Impact factor: 21.405

9.  Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.

Authors:  Yury Popov; Eleonora Patsenker; Felix Stickel; Jessica Zaks; K Ramakrishnan Bhaskar; Gerald Niedobitek; Armin Kolb; Helmut Friess; Detlef Schuppan
Journal:  J Hepatol       Date:  2008-01-14       Impact factor: 25.083

10.  Short telomeres are a risk factor for idiopathic pulmonary fibrosis.

Authors:  Jonathan K Alder; Julian J-L Chen; Lisa Lancaster; Sonye Danoff; Shu-chih Su; Joy D Cogan; Irma Vulto; Mingyi Xie; Xiaodong Qi; Rubin M Tuder; John A Phillips; Peter M Lansdorp; James E Loyd; Mary Y Armanios
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

View more
  6 in total

1.  The prognostic and immune infiltration role of ITGB superfamily members in non-small cell lung cancer.

Authors:  Juan Wu; Wenjun Wang; Zhouhua Li; Xiaoqun Ye
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 2.  COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.

Authors:  Alison E John; Chitra Joseph; Gisli Jenkins; Amanda L Tatler
Journal:  Immunol Rev       Date:  2021-05-24       Impact factor: 10.983

3.  Regulation of transforming growth factor-β signalling by SUMOylation and its role in fibrosis.

Authors:  Xinyi Wang; Ting Liu; Yifei Huang; Yifeng Dai; Hui Lin
Journal:  Open Biol       Date:  2021-11-10       Impact factor: 6.411

4.  Lysyl oxidase like 2 is increased in asthma and contributes to asthmatic airway remodelling.

Authors:  Jopeth Ramis; Robert Middlewick; Francesco Pappalardo; Jennifer T Cairns; Iain D Stewart; Alison E John; Shams-Un-Nisa Naveed; Ramaswamy Krishnan; Suzanne Miller; Dominick E Shaw; Christopher E Brightling; Lee Buttery; Felicity Rose; Gisli Jenkins; Simon R Johnson; Amanda L Tatler
Journal:  Eur Respir J       Date:  2022-07-07       Impact factor: 33.795

5.  Exploration and validation of hub genes and pathways in the progression of hypoplastic left heart syndrome via weighted gene co-expression network analysis.

Authors:  Xuelan Liu; Honglei Shang; Bin Li; Liyun Zhao; Ying Hua; Kaiyuan Wu; Manman Hu; Taibing Fan
Journal:  BMC Cardiovasc Disord       Date:  2021-06-15       Impact factor: 2.298

6.  Demystifying pulmonary fibrosis.

Authors:  Gisli Jenkins
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-05       Impact factor: 5.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.